(n=102, L=130) A post-market study to evaluate the safety and performance of LithiX™ HC-IVL in a real-world population with highly complex calcified lesions. The study showed: 96.1% freedom from MACE (30 days) 96.3% residual stenosis 113.71% overall mean stent expansion The post MY-IVL appeared first on Elixir Medical .
Discovery
Learnings
- auto_storiesStories
- categoryAreas
- helpFAQ
- forumConversations
- descriptionPapers
- mailNewsletters
- video_libraryVideos
- timelineTimeline
Guidance
- codeTechnology of APIs
- business_centerBusiness of APIs
- campaignEvangelism of APIs
- gavelGovernance of APIs
- historyHistory of APIs
- account_balancePolitics of APIs
Toolbox
- domainProviders
- apiAPIs
- cloudSolutions
- buildTools
- verifiedStandards
- gavelRegulations
- horizontal_ruleHeaders
- layersOverlays
- extensionExtensions
- schemaSchema
- policyPolicies
- ruleRules